BCL2L1 and lung cancer: As a potential antitumorigenic molecule, overexpression of STAT3β inhibits the transcriptional activity of STAT3α, down-regulates the anti-apoptotic gene Bcl-xL and the cell cycle-related gene cyclin D1, and suppresses the proliferation of lung cancer cells [168].